Theranostics Health creates value and gives insight to our customers.
The Company is highly motivated to work with other companies and academic institutions in the pursuit of our mission: to provide the right medicine to the right person at the right time.
Phosphoproteomic Network Analysis –
Our proteomic array services can measure and profile signaling pathways and provide critical information about post-translational modifications in the cell.
Drug Development -
Theranostics Health will work with pharmaceutical and biotech companies to identify and characterize appropriate protein kinase drug targets and small molecule inhibitors of these enzymes.
Diagnostics Development -
We are also looking for diagnostics companies that may wish to co-develop diagnostic reagents and tests. We are also willing to work with clinician scientists in universities and hospitals to investigate human samples for potential disease diagnostic biomarkers.
Bioinformatics Development -
Theranostics Health is interested in collaborating with academic and industrial organizations with bioinformatics expertise for analysis of our data for the purposes of signal transduction pathway mapping, and disease marker and drug target identification.
Antibody Development and Characterization -
We are always open to collaborating with producers and vendors of immunological reagents to create new antibodies or for testing their existing antibody inventories for inclusion in our proteomics services.
Theranostics Health also enters into academic collaborative projects with university scientists each year in the pursuit of ground-breaking research. If you have an interesting proposal, send us a short 1 page outline and we will give it serious consideration. For corporate development opportunities, please contact:
Debra A. Hope, Ph.D., MBA
Director of Business Development, Pharmaceutical
E-mail: hope@Theranosticshealth.com
Phone: 301-351-7194
